Afzal Rehman is a Cardiology physician affiliated with United Health Services. OpenAlex indexes 32 publications with 206 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
30 Harrison St Ste 250
Johnson City, NY 137902176
Telephone
607-770-8600Registry record last updated 17 Oct 2017.
Industry payments
38 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20255 payments
- GE HEALTHCAREProgram year20251 payment
- Kestra Medical Technology Services, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
73%Beta blocker28.7%Metoprolol Succinate54%Carvedilol46%Part D≥21 patientsStatin17%Atorvastatin Calcium54%Rosuvastatin Calcium46%Part D≥12 patients+ 4 more classes in this area
Blood & clotting
17%Factor Xa inhibitor10.3%Eliquis100%Part D≥12 patientsVitamin K antagonist6.7%Warfarin Sodium100%Part D<11 patientsMetabolism & gastrointestinal
9.9%SGLT2 inhibitor9.9%Jardiance100%Part D≥18 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Early versus late oral anticoagulants after acute ischemic stroke in atrial fibrillation patients: a meta-analysis of randomized controlled trials
Baylor University Medical Center Proceedings
2026 - Cardiovascular outcomes with SGLT-2 inhibitors in individuals with diabetes and co-existing atrial fibrillation: A systematic review and meta-analysis
International Journal of Cardiology
2025 - Liberal versus restrictive red blood cell transfusion strategy in acute coronary syndrome and anemia: an updated systematic review and meta-analysis
Frontiers in Cardiovascular Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”